Jiancong Hu

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

Huabin Hu, Liang Kang, Jianwei Zhang et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 278 citations

Neoadjuvant Pd-1 Blockade, Medicine, Immunology +7

Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells

Qian Zhang, Ruixian Liu, Ka‐Wo Chan et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 163 citations · Full text

Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis

Tuo Hu, Huashan Liu, Zhenxing Liang et al. · Theranostics · 2020 · 141 citations · Full text

Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation

Qiulan He, Changpeng Han, Liang Huang et al. · Journal of Cellular and Molecular Medicine · 2020 · 81 citations · Full text

Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics

Pengfei Qin, Huaxian Chen, Yuhang Wang et al. · Cell Reports Medicine · 2023 · 71 citations · Full text